- Home
- PHAR vs TGB Comparison
PHAR vs TGB Comparison
Compare PHAR & TGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- TGB
- Stock Information
- Founded
- PHAR 1988
- TGB 1966
- Country
- PHAR Netherlands
- TGB Canada
- Employees
- PHAR N/A
- TGB N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- TGB Precious Metals
- Sector
- PHAR Health Care
- TGB Basic Materials
- Exchange
- PHAR Nasdaq
- TGB Nasdaq
- Market Cap
- PHAR 718.1M
- TGB 698.1M
- IPO Year
- PHAR N/A
- TGB N/A
- Fundamental
- Price
- PHAR $10.45
- TGB $2.81
- Analyst Decision
- PHAR Strong Buy
- TGB
- Analyst Count
- PHAR 3
- TGB 0
- Target Price
- PHAR $30.00
- TGB N/A
- AVG Volume (30 Days)
- PHAR 2.6K
- TGB 14.1M
- Earning Date
- PHAR 07-31-2025
- TGB 07-30-2025
- Dividend Yield
- PHAR N/A
- TGB N/A
- EPS Growth
- PHAR N/A
- TGB N/A
- EPS
- PHAR N/A
- TGB N/A
- Revenue
- PHAR $320,708,000.00
- TGB $417,640,101.00
- Revenue This Year
- PHAR $13.31
- TGB $22.13
- Revenue Next Year
- PHAR $7.68
- TGB $36.13
- P/E Ratio
- PHAR N/A
- TGB N/A
- Revenue Growth
- PHAR 24.13
- TGB 7.89
- 52 Week Low
- PHAR $6.65
- TGB $1.67
- 52 Week High
- PHAR $12.61
- TGB $3.14
- Technical
- Relative Strength Index (RSI)
- PHAR 47.51
- TGB 58.69
- Support Level
- PHAR $10.41
- TGB $2.85
- Resistance Level
- PHAR $11.50
- TGB $3.02
- Average True Range (ATR)
- PHAR 0.32
- TGB 0.15
- MACD
- PHAR -0.17
- TGB 0.01
- Stochastic Oscillator
- PHAR 2.26
- TGB 60.59
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
About TGB Taseko Mines Ltd.
Taseko Mines Ltd is a Canadian mining company. It is principally engaged in the production and sale of metals, as well as related activities, including exploration and mine development, within the province of British Columbia, Canada, and the State of Arizona, the United States. The Gibraltar, Aley, New Prosperity, Yellowhead properties are located in British Columbia whereas Florence copper is in central Arizona.